{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T18:36:23Z","timestamp":1783881383471,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"am","delay-in-days":295,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.anl.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T06:37:58Z","timestamp":1711175878000},"page":"501-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current management of carotid body tumors"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0990-831X","authenticated-orcid":false,"given":"Hiroyuki","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2024.01.007_bib0001","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1210\/jcem.86.11.8034","article-title":"Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients","volume":"86","author":"Erickson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anl.2024.01.007_bib0002","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41416-019-0474-x","article-title":"A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial","volume":"120","author":"O'Kane","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anl.2024.01.007_bib0003","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9610(96)00151-1","article-title":"Carotid body tumors, inheritance, and a high incidence of associated cervical paragangliomas","volume":"172","author":"Gardner","year":"1996","journal-title":"Am J Surg"},{"key":"10.1016\/j.anl.2024.01.007_bib0004","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anl.2024.01.007_bib0005","doi-asserted-by":"crossref","first-page":"e1937","DOI":"10.1210\/clinem\/dgaa982","article-title":"Metastatic pheochromocytomas and abdominal paragangliomas","volume":"106","author":"Granberg","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anl.2024.01.007_bib0006","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cncr.10252","article-title":"National cancer data base report on malignant paragangliomas of the head and neck","volume":"94","author":"Lee","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.anl.2024.01.007_bib0007","doi-asserted-by":"crossref","first-page":"E194","DOI":"10.1177\/000313481307900507","article-title":"Hepatic metastasis of a carotid body paraganglioma 5 years after resection of the primary tumor","volume":"79","author":"Moris","year":"2013","journal-title":"Am Surg"},{"issue":"Suppl 1","key":"10.1016\/j.anl.2024.01.007_bib0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6061\/clinics\/2012(Sup01)05","article-title":"Head and neck paragangliomas: clinical and molecular genetic classification","volume":"67","author":"Offergeld","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.anl.2024.01.007_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101416","article-title":"An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma","volume":"34","author":"Buffet","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.anl.2024.01.007_bib0010","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/0008-5472.CAN-08-4057","article-title":"Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out","volume":"69","author":"Neumann","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.anl.2024.01.007_bib0011","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s00268-015-3058-9","article-title":"Preoperative imaging features are associated with surgical complications following carotid body tumor resection","volume":"39","author":"Straughan","year":"2015","journal-title":"World J Surg"},{"key":"10.1016\/j.anl.2024.01.007_bib0012","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejvs.2013.01.018","article-title":"Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations","volume":"45","author":"Fruhmann","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.anl.2024.01.007_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164014","article-title":"Prevalence of germline variants in a large cohort of japanese patients with pheochromocytoma and\/or paraganglioma","volume":"13","author":"Yonamine","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.anl.2024.01.007_bib0014","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/cge.14294","article-title":"Molecular basis of carotid body tumor and associated clinical features in Japan identified by genomic, immunohistochemical, and clinical analyses","volume":"103","author":"Yoshihama","year":"2023","journal-title":"Clin Genet"},{"key":"10.1016\/j.anl.2024.01.007_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.614908","article-title":"Mutation frequency in main susceptibility genes among patients with head and neck paragangliomas","volume":"11","author":"Snezhkina","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.anl.2024.01.007_bib0016","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/00016489.2020.1845397","article-title":"Head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment","volume":"141","author":"Rana","year":"2021","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2024.01.007_bib0017","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","article-title":"Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients","volume":"52","author":"Currras-Freixes","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.anl.2024.01.007_bib0018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jmedgenet-2020-107102","article-title":"Characteristics of germline mutations in Korean patients with pheochromocytoma\/paraganglioma","volume":"59","author":"Kim","year":"2022","journal-title":"J Med Genet"},{"key":"10.1016\/j.anl.2024.01.007_bib0019","article-title":"Germline genetic variants in pheochromocytoma\/paraganglioma: single-center experience","volume":"3","author":"Lima","year":"2023","journal-title":"Endocr Oncol"},{"key":"10.1016\/j.anl.2024.01.007_bib0020","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","article-title":"The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas","volume":"94","author":"Burnichon","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anl.2024.01.007_bib0021","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing","volume":"91","author":"Brouwers","year":"2006","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.anl.2024.01.007_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102389","article-title":"Mutation profile of aggressive pheochromocytoma and paraganglioma with comparison of TCGA data","volume":"13","author":"Choi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.anl.2024.01.007_bib0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"Nolting","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.anl.2024.01.007_bib0024","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejvs.2018.10.038","article-title":"A systematic review and meta-analysis of the presentation and surgical management of patients with carotid body tumours","volume":"57","author":"Robertson","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.anl.2024.01.007_bib0025","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/1097-0142(20000615)88:12<2811::AID-CNCR21>3.0.CO;2-7","article-title":"Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal","volume":"88","author":"Jansen","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.anl.2024.01.007_bib0026","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/MAO.0000000000000386","article-title":"The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas","volume":"35","author":"Prasad","year":"2014","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2024.01.007_bib0027","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13244-019-0701-2","article-title":"Multimodality imaging of paragangliomas of the head and neck","volume":"10","author":"Thelen","year":"2019","journal-title":"Insights Imaging"},{"key":"10.1016\/j.anl.2024.01.007_bib0028","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/jon.12351","article-title":"Dynamic contrast-enhanced MRI in the evaluation of carotid space paraganglioma versus schwannoma","volume":"26","author":"Gaddikeri","year":"2016","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.anl.2024.01.007_bib0029","first-page":"1839","article-title":"Diagnostic role of diffusion-weighted and dynamic contrast-enhanced perfusion mr imaging in paragangliomas and schwannomas in the head and neck","volume":"42","author":"Ota","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.anl.2024.01.007_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neurad.2018.10.002","article-title":"Descending musculospinal branch of the ascending pharyngeal artery as a feeder of carotid body tumors: angio-architecture and embryological consideration","volume":"47","author":"Shibao","year":"2020","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.anl.2024.01.007_bib0031","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jvs.2012.11.086","article-title":"Double osteotomy of mandibula in the treatment of carotid body tumors with skull base extension","volume":"58","author":"Prouse","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.anl.2024.01.007_bib0032","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0002-9610(71)90436-3","article-title":"Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases","volume":"122","author":"Shamblin","year":"1971","journal-title":"Am J Surg"},{"key":"10.1016\/j.anl.2024.01.007_bib0033","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00405-020-05975-z","article-title":"Management and outcomes of vascular reconstruction in carotid body tumor resection: retrospective analysis of 60 cases","volume":"277","author":"Sevil","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2024.01.007_bib0034","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3174\/ajnr.A1092","article-title":"Carotid body tumors: objective criteria to predict the Shamblin group on MR imaging","volume":"29","author":"Arya","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.anl.2024.01.007_bib0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5152\/dir.2021.20028","article-title":"Imaging criteria to predict Shamblin group in carotid body tumors - revisited","volume":"27","author":"Jasper","year":"2021","journal-title":"Diagn Interv Radiol"},{"issue":"Suppl 1","key":"10.1016\/j.anl.2024.01.007_bib0036","first-page":"E2386","article-title":"Impact of preoperative embolization on the outcomes of carotid body tumor surgery: a meta-analysis and review of the literature","volume":"38","author":"Abu-Ghanem","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2024.01.007_bib0037","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.avsg.2020.03.030","article-title":"Carotid body tumor resection: long-term outcome of 67 cases without preoperative embolization","volume":"67","author":"Sevil","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.anl.2024.01.007_bib0038","article-title":"Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization","volume":"13","author":"Han","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.anl.2024.01.007_bib0039","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jocn.2013.11.012","article-title":"The glomic artery supply of carotid body tumors and implications for embolization","volume":"21","author":"Telischak","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.anl.2024.01.007_bib0040","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1007\/s00405-023-07990-2","article-title":"Preoperative embolization is necessary for large-volume carotid body tumor (\u22656670mm3) resection","volume":"280","author":"Nan","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2024.01.007_bib0041","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.avsg.2021.01.074","article-title":"Improving outcomes in carotid body tumors treatment: the impact of a multidisciplinary team approach","volume":"75","author":"Menegolo","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.anl.2024.01.007_bib0042","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.adro.2017.11.002","article-title":"External beam radiation therapy for advanced\/unresectable malignant paraganglioma and pheochromocytoma","volume":"3","author":"Breen","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.anl.2024.01.007_bib0043","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00405-013-2384-5","article-title":"Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy","volume":"271","author":"Suarez","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2024.01.007_bib0044","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1200\/JCO.2008.16.6546","article-title":"Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2024.01.007_bib0045","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12542","article-title":"Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis","volume":"81","author":"Niemeijer","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.anl.2024.01.007_bib0046","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11864-020-00787-z","article-title":"Emerging treatments for advanced\/metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Ilanchezhian","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.anl.2024.01.007_bib0047","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/ijc.28913","article-title":"SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma","volume":"135","author":"Hadoux","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anl.2024.01.007_bib0048","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/clinem\/dgac471","article-title":"Targeted therapies in pheochromocytoma and paraganglioma","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anl.2024.01.007_bib0049","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1530\/ERC-20-0043","article-title":"Antiangiogenic therapies for pheochromocytoma and paraganglioma","volume":"27","author":"Jimenez","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.anl.2024.01.007_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082307","article-title":"Phase II clinical trial of pembrolizumab in patients with progressive metastatic pheochromocytomas and paragangliomas","volume":"12","author":"Jimenez","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.anl.2024.01.007_bib0051","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2967\/jnumed.118.217463","article-title":"Efficacy and safety of high-specific-activity (131)I-MIBG therapy in patients with advanced pheochromocytoma or paraganglioma","volume":"60","author":"Pryma","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.anl.2024.01.007_bib0052","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12149-020-01541-z","article-title":"131)I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with (177)Lu-DOTATATE peptide receptor radionuclide therapy","volume":"35","author":"Parghane","year":"2021","journal-title":"Ann Nucl Med"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814624000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814624000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T20:08:17Z","timestamp":1715112497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814624000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0385814624000154"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2024.01.007","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current management of carotid body tumors","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}